Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mend After Cancer is a digital health company focused on improving the quality of life for cancer survivors, with a primary emphasis on breast cancer recovery. The company provides a comprehensive platform that offers personalized survivorship care plans, physical therapy exercises, and educational resources to address long-term side effects of treatment. By integrating clinical expertise with digital accessibility, Mend aims to bridge the gap between active treatment and long-term recovery. Their services are designed to help patients manage physical and emotional challenges such as lymphedema, fatigue, and mobility issues following surgery or radiation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mend After Cancer.